Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.003 Å; R factor = 0.026; wR factor = 0.065; data-to-parameter ratio = 17.5.
The structure of the title compound, [Fe(C 5 H 5 )(C 15 H 13 O 2 )], consists of a ferrocenyl moiety and a 2-methoxyphenyl group linked through a prop-2-en-1-one spacer in an E conformation. In the ferrocene unit, the substituted cyclopentadienyl (Cps) ring and the unsubstituted cyclopentadienyl ring (Cp) are almost parallel to one another [dihedral angle = 1.78 (14) ], and the Cp and Cps rings are in a gauche conformation. The benzene ring is twisted by 10.02 (14) and 11.38 (11) with respect to the Cp and Cps rings, respectively. In the crystal, molecules are linked by weak C-HÁ Á ÁO hydrogen bonds into supramolecular chains running along the b-axis direction.
Related literature
For the synthesis, see: Attar et al. (2011); Kumar et al. (2012) . For related syntheses and background, see: Liu et al. (2001) ; Wu et al. (2002) ; Ji et al. (2003) ; Maree et al. (2008) ; Jiao et al. 
Experimental
Crystal data [Fe(C 5 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx; y À 1 2 ; Àz þ 3 2 .
Data collection: APEX2 (Bruker, 2007); cell refinement: SAINT (Bruker, 2007); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL. Chalcones occur in nature as precursors of flavonoids and exhibit various biological activities such as anti-cancer, antiinflammatory, nitric oxide regulation and anti-hyperglycemic agents (Liu et al., 2001) . They are traditionally synthesized in the laboratory, via the Claisen-Schmidt condensation carried out in basic or acidic media under homogeneous conditions (Attar et al., 2011) . Structural modifications of the chalcone template are readily achieved. Biological activities of chalcones are equally wide ranging, such as: anti-bacterial and anti-hyperglycemic, anti-malarial, anti-HIV, anti-oxidant, and anti-tumor (Wu et al., 2002) .
The crystal structure of the title compound reveals that the configuration about the C12═C13 bond corresponds to the (E)-isomer. The majority of the C and O atoms of the substituted cyclopentadienyl ring (Cps) are sp 2 -hybridized and the conjugation is lost at the methoxy substituent of C19. In the ferrocenyl moiety, the planes formed by the Cp (unsubstituted cyclopentadienyl ring) and Cps are almost parallel. The C atoms in these two rings have adopted a gauche conformation, and the Fe metal center lies closer to the Cps ring. The Fe-Cg and Fe-Cgs distances are 1.658 (2) and 1.644 (2) Å, respectively, where Cg and Cgs are the centroids of Cp and Cps, respectively. The Cg-Fe-Cgs angle is 178.4 (2)°.
The title compound was synthesized according to the literature procedure (Cardona et al., 2010) . An aqueous solution of sodium hydroxide (5%, 2 ml) was added slowly with stirring to acetylferrocene (0.456 g, 0.002 mol). Then, 2-methoxybenzaldehyde (0.272 g, 0.002 mol) in ethanol (2 ml). The resulting mixture was stirred at room temperature for 2 h. The dark-orange-red precipitated solid was filtered off, washed with cold water and ethanol, dried and recrystallized from a mixture of acetone:water (yield, 84%; M·P. 144-145 °C). Dark violet crystals, suitable for X-ray diffraction, were obtained by the slow evaporation of a 1:1 (v/v) acetone:water solution of the title compound at room temperature over a period of 1 day. NMR analyses were performed on a Bruker AV-500 spectrometer by using CDCl 3 99.9% pure as a 72.5, 80.9, 111.2, 123.9, 120.7, 124.7, 128.9, 131.2, 136.3, 158.7, 193.5 .
Refinement
H atoms were placed in calculated positions with C-H = 0.93-0.96 Å and refined in riding mode with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C) for the others.
Computing details
Data collection: APEX2 (Bruker, 2007); cell refinement: SAINT (Bruker, 2007); data reduction: SAINT (Bruker, 2007); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 supplementary materials sup-2 Acta Cryst. (2014). E70, m108-m109 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication:
SHELXTL (Sheldrick, 2008) .
Figure 1
The molecular structure of the title compound. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. (3) 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )

